Dr. Rajendar Burki | Analytical Chemistry | Best Researcher Award
Biological E Limited, India
👨🎓Profiles
👨🎓 Early Academic Pursuits
His academic foundation began with a Bachelor of Science in Microbiology and Chemistry from Kakatiya University, India, which he completed in April 2000. His educational journey continued with a Master of Science in Analytical Chemistry from NIT Warangal (Deemed University), awarded. He further advanced his knowledge and expertise by earning a Ph.D. in Bioanalytical/Biological Chemistry from Tohoku University, Japan. His doctoral and postdoctoral experiences equipped him with the rigorous scientific acumen required for pioneering work in protein biochemistry and analytical research.
💼 Professional Endeavors
He has a distinguished career spanning over two decades, marked by leadership and significant contributions in the field of vaccine research and development. Since, he has been with Biological E Limited in Hyderabad, where he serves as Vice President of Research and Development. In this capacity, he leads a team of over 30 scientists and plays a crucial role in vaccine R&D, encompassing recombinant proteins, bacterial, viral, and VLP vaccines. His experience includes product development from initial concepts to late-stage clinical material manufacturing (CMC expertise), process development, analytical sciences, and biophysical analysis.
🌟 Key Roles and Responsibilities
Regulatory Expertise: Dr. Burki has spearheaded regulatory documentation and submissions for various vaccine projects, ensuring thorough analytical and process development. Team and Resource Management: He excels in building and managing skilled teams, overseeing space planning, budget allocation, and resource optimization. Documentation and Compliance: Authored and reviewed critical documents including MFRs, BPRs, SOPs, and reports on method development, qualification, and validation.
🏆 Contributions and Achievements
He has led numerous groundbreaking projects in vaccine development that have significantly impacted public health. His notable achievements include: Approval and Development: Instrumental in obtaining PCV vaccine approval for Biological E, Methodology Development: Created and validated analytical methods for bacterial and viral vaccines, Process Engineering: Pioneered conjugation and downstream processes for mono-conjugate preparation, Formulation Optimization: Designed and enhanced formulations for various vaccine types, Technology Transfer: Successfully managed the transfer of processes and analytical methods to production and quality control units, Regulatory Success: Played an essential role in preparing technical packages for submissions to PCT (RCGM), CDSCO, WHO, and FDA.
🧪 Research Focus and Impact
His research is highly focused on the fields of protein expression, characterization, and vaccine development. His early career work at the University of Alabama at Birmingham involved exploring the molecular mechanisms of the ClpA molecular chaperone, including protein cloning, expression, purification, and binding analysis of peptide substrates. This foundational work in biophysical chemistry has contributed to his later expertise in analytical and biophysical methods, particularly for characterizing complex biological molecules.
📚 Academic Citations and Recognition
His contributions have earned him recognition and accolades, underscoring his influence in the scientific community: JST Doctoral Fellowship: Awarded during his Ph.D. program, showcasing his academic prowess, Postdoctoral Fellowship: Secured for advanced research at the University of Alabama, Biopharma Leadership Award (2022): Presented by Bluetech Media in acknowledgment of his leadership in the biopharmaceutical industry, FDD Leaders Award (2023): Honored by Express Pharma, recognizing his exceptional leadership and impact in vaccine development.
💻 Technical Skills
He is highly skilled in a range of analytical and biophysical techniques, essential for protein characterization and vaccine development: Chromatography: Proficient in protein expression, purification, and analysis, Spectroscopy and Fluorescence Studies: Used for in-depth biochemical investigations, Enzyme Kinetics: Applied for understanding enzyme functionality, Analytical Method Development: Expertise in developing and validating methods for both small molecules and large biomolecules.
🎓 Teaching Experience
Throughout his career, Dr. Burki has shared his expertise through mentoring and training in analytical techniques and biophysical methodologies. His experience as a postdoctoral researcher included training peers and contributing to research team learning in protein analysis and purification techniques.
🌱 Legacy and Future Contributions
His leadership at Biological E Limited and his prior work have cemented his legacy as a trailblazer in vaccine R&D and analytical biochemistry. Looking ahead, his goal is to continue advancing the science of vaccine development and contribute to global health through innovative research and fostering the next generation of scientific leaders. With his expertise, he is set to influence future developments in vaccine technology, analytical methodologies, and cross-disciplinary collaboration.
📖Notable Publications
- Quantitative determination of C-polysaccharide in Streptococcus pneumoniae capsular polysaccharides by enzyme-linked immunosorbent assay
- Authors: Paliwal, P.K., Rajendar, B., Nagarajan, T., Tripathi, A., Matur, R.V.
Journal: Journal of Immunological Methods
Year: 2024
- O-phthalaldehyde based quantification of polysaccharide modification in conjugate vaccines
- Authors: Rajendar, B., Reddy, M.V.N.J., Suresh, C.N.V., Rao, G.S., Matur, R.V.
Journal: Journal of Pharmaceutical and Biomedical Analysis
Year: 2024
- Upstream process development for the production of DNA vaccines using bioreactors
- Authors: Prasad, K.S., Rajendar, B., Prasad, P.
Journal: Bioreactor Design Concepts for Viral Vaccine Production (Book Chapter)
Year: 2024
- Individual polysaccharide quantification in polyvalent pneumococcal conjugate vaccine using rate nephelometry
- Authors: Rajendar, B., Pydigummala, J.S., Rao, G.S., Chigurambotla, R., Matur, R.V.
Journal: Journal of Immunological Methods
Year: 2023
- Multi angle light scattering as a process analytical technology tool for real-time monitoring of molar mass of protein-polysaccharide conjugate fractions
- Authors: Rajendar, B., Reddy, M.J., Madhavi, A., Rao, G.S., Matur, R.V.
Journal: Journal of Chromatography Open
Year: 2022
- High-Performance Anion-Exchange chromatography with conductivity detection method for simultaneous determination of nitrogen and phosphorus in polysaccharides
- Authors: Rajendar, B., Janardhan Reddy, M.V.N., Mulagalapati, R., Adusumilli, M., Matur, R.V.
Journal: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Year: 2022
- A reversed phase HPLC-UV method for the simultaneous determination of residual formaldehyde and Triton X-100 in vaccine products
- Authors: Rajendar, B., Janardhan Reddy, M.V.N., Suresh, C.N.V., Gambheerrao, S.K., Matur, R.V.
Journal: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Year: 2021
- Determination of free carrier protein in glycoconjugate vaccines by size exclusion chromatography–high performance liquid chromatography with fluorescence detector
- Authors: Rajendar, B., Reddy, M.V.N.J., Suresh, C.N.V., Bheemaraju, S., Matur, R.V.
Journal: Separation Science Plus
Year: 2021